The recent terrorist attacks in Paris were executed with guns and bombs in the physical terrain of city streets and cafe terraces. But the horrific incident is reviving government calls for greater control of the cyber environment.
A host of top... Read more »
The problems in healthcare are vast, and the potential solutions are wide-ranging.
But as we saw at Xconomy’s annual Healthcare Summit this week, tackling today’s challenges in healthcare requires a combination of good ideas, laser focus, and plenty of help from... Read more »
Former Sanofi CEO Chris Viehbacher was handed the keys to a big biotech fund from Gurnet Point Capital a few months ago, and today he announced what he’s doing with it.
Viehbacher (pictured above) will become the chairman of a new... Read more »
A slew of companies have gone public amidst gene therapy’s recent renaissance, and technological advances have gotten these types of treatments closer than they’ve ever been to impacting healthcare in the U.S.
But today, Celladon offered a reminder of how quickly... Read more »
You can learn a lot about doing great science, building big companies, and even living a healthy life, by listening to the right group of people.
Of course you also have to do stuff yourself—not just listen—but getting exposed to the... Read more »
[Updated 11/19/15, 4:33 pm. See below.] It’s a disappointing day for tech IPOs in Boston and elsewhere.
Mimecast, a U.K. e-mail management and security firm with a significant presence in Watertown, MA, is set to go public Thursday with... Read more »
Last week, we announced that a stealth company would make its public debut at this afternoon’s (Tuesday, November 17) Healthcare Summit at the Broad Institute in Kendall Square. Now we can tell you that the company is Codiak BioSciences and... Read more »
As consumers, we’ve all had a frustrating experience (or several) talking with a customer service representative on the phone. Maybe the voice on the other end of the line was speaking too quickly, not really answering your question, or simply being... Read more »
Should drug companies publicly release all data from the tests they conduct on human volunteers? A growing number of parties say yes, and last week, a group of academics unveiled a scorecard to spotlight companies that have recently kept their clinical... Read more »